295 related articles for article (PubMed ID: 16898458)
1. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
[TBL] [Abstract][Full Text] [Related]
2. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
[TBL] [Abstract][Full Text] [Related]
3. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
[TBL] [Abstract][Full Text] [Related]
4. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
[TBL] [Abstract][Full Text] [Related]
5. On the use of high dose rate 192Ir and 169Yb sources with the MammoSite radiation therapy system.
Papagiannis P; Karaiskos P; Georgiou E; Baltas D; Lymperopoulou G; Pantelis E; Sakelliou L
Med Phys; 2007 Sep; 34(9):3614-9. PubMed ID: 17926965
[TBL] [Abstract][Full Text] [Related]
6. Radiation transmission data for radionuclides and materials relevant to brachytherapy facility shielding.
Papagiannis P; Baltas D; Granero D; Pérez-Calatayud J; Gimeno J; Ballester F; Venselaar JL
Med Phys; 2008 Nov; 35(11):4898-906. PubMed ID: 19070223
[TBL] [Abstract][Full Text] [Related]
7. EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources.
Taylor RE; Rogers DW
Med Phys; 2008 Nov; 35(11):4933-44. PubMed ID: 19070227
[TBL] [Abstract][Full Text] [Related]
8. Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
Patel NS; Fan P; Chiu-Tsao ST; Ravi K; Sherman W; Quon H; Pisch J; Tsao HS; Harrison LB
Cardiovasc Radiat Med; 2001; 2(3):173-80. PubMed ID: 11786324
[TBL] [Abstract][Full Text] [Related]
9. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
Mainegra E; Capote R; López E
Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
[TBL] [Abstract][Full Text] [Related]
10. Air-kerma strength determination of a 169Yb high dose rate brachytherapy source.
VanDamme JJ; Culberson WS; DeWerd LA; Micka JA
Med Phys; 2008 Sep; 35(9):3935-42. PubMed ID: 18841844
[TBL] [Abstract][Full Text] [Related]
11. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
14. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
Melhus CS; Rivard MJ
Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
[TBL] [Abstract][Full Text] [Related]
15. Determination of absorbed dose in water at the reference point d(r0, theta0) for an 192Ir HDR brachytherapy source using a Fricke system.
Austerlitz C; Mota HC; Sempau J; Benhabib SM; Campos D; Allison R; DeAlmeida CE; Zhu D; Sibata CH
Med Phys; 2008 Dec; 35(12):5360-5. PubMed ID: 19175095
[TBL] [Abstract][Full Text] [Related]
16. MONTE CARLO-BASED INVESTIGATION OF MICRODOSIMETRIC DISTRIBUTION OF HIGH ENERGY BRACHYTHERAPY SOURCES.
Chattaraj A; Selvam TP; Datta D
Radiat Prot Dosimetry; 2019 Dec; 187(1):115-128. PubMed ID: 31165891
[TBL] [Abstract][Full Text] [Related]
17. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of scatter contribution and distance error by iterative methods for strength determination of HDR 192Ir brachytherapy source.
Kumar S; Srinivasan P; Sharma SD; Subbaiah KV; Mayya YS
Med Dosim; 2010; 35(3):230-7. PubMed ID: 19931038
[TBL] [Abstract][Full Text] [Related]
19. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
20. Development of a scatter correction technique and its application to HDR 192Ir multicatheter breast brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Aug; 36(8):3703-13. PubMed ID: 19746803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
